Charlotte Maxeke Johannesburg Academic Hospital

Johannesburg 2193

4 studies enrolling now · 10 studies all time

What they study most

Blood Coagulation Disorder, Blood Coagulation Disorders, Inherited, Haematologic Disease, Hemophilia B, Hepatocellular Carcinoma, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH), Rheumatoid Arthritis, Sickle Cell Anemia, Sickle Cell Disease, Staphylococcus Aureus Bacteremia, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease — Recruiting now
• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis — Recruiting now
• Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
• Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) — Recruiting now
• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment — Running, not enrolling
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir — Completed
• A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) — Running, not enrolling
• AAV Gene Therapy Screening/Observational Protocol (ECLIPSE) — Completed
• A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone — Completed